PRDM1 and Miyoshi myopathy: Although earlier studies showed that EZH2 inhibition reduces expression of IRF4, MYC, and PRDM1 in MM, we found that the dual EZH2/G9a inhibition exerted greater suppressive effects than inhibition of either enzyme alone8,9.